Concepción Carrascosa

Concepción Carrascosa

Auto-generated profile, based on publicly available information

Concepción Carrascosa

Department of Obstetrics and Gynaecology, Virgen de La Arrixaca University Hospital, Murcia, Spain

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2026 in European Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MNMaría García Nicolás
María García Nicolás
María Paula Jarrín OrozcoMaría Paula Jarrín Orozco
María Paula Jarrín Orozco
MVMaría Romo Vaquero
María Romo Vaquero
CCConcepción Carrascosa
Concepción Carrascosa
FAFrancisco Avilés-Plaza
Francisco Avilés-Plaza
Juan Carlos EspínJuan Carlos Espín
Juan Carlos Espín
Purpose: Menopause increases cardiometabolic risk via dyslipidaemia, oxidative stress, and low-grade inflammation. Polyphenols may modulate these processes, but human evidence is inconsistent. We investigated the effects of polyphenol supplementation on lipid profile, LDL oxidation, and polyphenol-related gut microbiota metabotypes in postmenopausal women. Methods: In the PolyPAUSE randomised, placebo-controlled, crossover trial, 90 mildly hypercholesterolemic, non-medicated postmenopausal women received a daily polyphenol mixture providing ellagitannins+ellagic acid (312.0 ± 30.9 mg), resveratrol (133.2 ± 10.1 mg), and isoflavones (166.3 ± 27.3 mg) for 8 weeks, followed by a 4-week washout and an 8-week placebo period. Serobiochemical and bone-related markers were analysed at hospital laboratories. Apolipoprotein B (ApoB), oxidised LDL (oxLDL), and lipopolysaccharide-binding protein (LBP) were measured by ELISA, and myeloperoxidase activity by spectrophotometry. Gut microbiota metabotypes were classified as urolithin A/B (UMA/UMB), equol producers/non‑producers (EP/ENP), and lunularin producers/non‑producers (LP/LNP) using UPLC‑ESI‑QTOF‑MS. Results: Polyphenol supplementation did not affect LBP or bone markers. Total cholesterol (Tchol), LDL-cholesterol (LDLc), and triglycerides (TGs) increased by 7%, 9.5%, and 16%, respectively ( p < 0.001) in ~ 80% of completers ( n = 78), with age‑related increases. ApoB showed a borderline reduction ( p = 0.056), and oxLDL decreased ( p < 0.001). Ratios indicating LDL particle quality and oxidative burden (LDLc/ApoB, oxLDL/LDLc, oxLDL/ApoB) improved ( p < 0.001) despite higher circulating lipid concentrations. Myeloperoxidase activity showed marginal decreases in the full cohort ( p = 0.08) and in LNP ( p = 0.06). Metabotyping showed that the strongest oxLDL reduction occurred in EP (65%, p < 0.001) and the UMA + EP+LNP cluster (60%, p < 0.001). Conclusion: Polyphenol supplementation increased Tchol, LDLc, and TGs age-dependently, yet improved LDL oxidative quality. The extent of oxLDL reduction depended on metabotypes, supporting precision health approaches to better characterise cardiometabolic responses to polyphenol intake in postmenopausal women.